Amino Minder Brings Real Pharmacokinetic Modeling to Peptide and GLP-1 Tracking, Now Live on the Web -- Android App Coming Soon

New tracker goes beyond dose logging to model estimated plasma levels over time, including downstream hormone cascades for GH-secretagogue stacks

KINGMAN, Ariz., Sept. 8, 2026 /PRNewswire/ -- Baya Lobo LLC today announced the web launch of Amino Minder (aminominder.com), a peptide, GLP-1, TRT, and HRT protocol tracker built around a feature no competing app currently claims: a real pharmacokinetic (PK) engine that estimates and graphs a user's plasma level for each tracked compound over time, rather than simply logging that a dose was taken.

Most peptide-tracking apps on the market function as digital logbooks — a calendar of doses, reminders, and inventory. Amino Minder's PK engine goes further, using standard one-compartment absorption/elimination modeling to show users a rise-and-decay curve for every compound they log, adjustable for route of administration, individual half-life, and a user-configurable clearance modifier. For compounds like the GHRH- and GHRP-class growth-hormone secretagogues — where the injected peptide triggers a downstream cascade of natural GH release, which in turn drives a separate, slower IGF-1 response — Amino Minder models that full chain, including synergy effects when GHRH- and GHRP-class compounds are stacked together, a combination known to produce a greater GH response than either compound alone.

"When I started my peptide journey, I couldn't find the app I wanted, at any cost. So we built it, and made it affordable," said Jim Hamilton, founder of Baya Lobo LLC.

Additional features include pre-built multi-compound stack templates (including commonly-used combinations like GLOW, KLOW, and Wolverine), a low-clutter inventory tracker, streaks and milestone tracking to support consistency, customizable dose reminders, and a polished PDF export designed to be shared with a doctor or research partner. Consistent with its position as an informational tracking tool — not a source of medical advice — Amino Minder deliberately does not include an AI chat assistant or any feature that suggests dosing decisions to users.

Amino Minder is priced at $1.99/month, $9.99/year, or $24.99 as a one-time lifetime purchase — undercutting every comparable app in the category, and one of the only ones offering a straightforward lifetime tier with no retroactively-added sub-tiers.

The web app is available now at aminominder.com. An Android app is in final preparation for Google Play, with iOS to follow.

About Amino Minder

Amino Minder is a product of Baya Lobo LLC, based in Kingman, Arizona. Amino Minder is intended for personal tracking and informational purposes only. It is not a medical device and does not provide medical advice.

Media Contact
Jim Hamilton
Baya Lobo LLC
[email protected]
(928)473-1591

SOURCE Amino Minder